About the Special Diabetes Program

The Special Statutory Funding Program for Type 1 Diabetes Research, or Special Diabetes Program, is a special funding program for research on the prevention and cure of type 1 diabetes that began in FY 1998. NIDDK administers the Special Diabetes Program on behalf of the Secretary of the Department of Health and Human Services, in collaboration with multiple NIH Institutes and Centers and the CDC, and with input from the Diabetes Mellitus Interagency Coordinating Committee.

The Special Diabetes Program has enabled the creation of unique, innovative, and collaborative research consortia and clinical trials networks focused on the prevention, treatment, and cure of type 1 diabetes. These consortia have made significant research progress and also generated numerous research resources for use by the broad scientific community. More information on research supported by the Program and the resulting scientific accomplishments are found in a Progress Report on the Special Type 1 Diabetes Program.

Legislative and Funding History of the Special Diabetes Program

The Special Diabetes Program supplements regularly appropriated funds that the NIH receives for diabetes research. Special Diabetes Program funding in total has been ~$3.39 billion over 26 years. It began with $30 million per year in FY 1998-2000, increased to $100 million per year in FY 2001-2003, and has remained at $150 million per year since FY 2004, except in years when the funding was reduced through automatic spending cuts (sequestration). Each law for the Program sets an end date, so the Program is limited in time and requires renewal (reauthorization) in law to continue.

Funds for the Program have been provided by the following legislation:

Note: The amounts authorized by the above laws have been periodically affected by “sequestration” (automatic spending cuts that occur through the withdrawal of funding for certain government programs.)

Last Reviewed May 2024